Catalina Lopez-Correa

Vice-President Sector Development & Chief Scientific Officer

Genome British Columbia Vancouver, Canada

Dr. Catalina Lopez-Correa is the Vice President, Sector Development and CSO at Genome British Columbia. With over 18 years of international experience in genomics and precision medicine, Dr. Lopez-Correa has held leadership positions in the private and public sector. Dr. Lopez-Correa holds an MD from UPB University in Colombia, a Masters in Genetics from Paris VII/Pasteur Institute, and a PhD in Medical Biosciences-Genetics from KULeuven in Belgium. Most recently, she was the Vice President and CSO, Scientific Affairs at Genome Quebec, where she was instrumental in developing competitive teams for national and provincial research projects, and raising the profile of Genome Quebec on the global stage. Previous experience also includes: Senior Scientist with Eli Lilly and Company where she was part of the Pharmacogenomics and Translational Medicine Group in charge of discovering and validating genetic/genomic biomarkers in different therapeutic areas (oncology, cardio-metabolic and neurosciences); and Head of Cytogenomics laboratory at deCODE genetics where she developed screening strategies to detect genomic rearrangements. Since 2002, Dr. Lopez-Correa has served as evaluator for large multinational projects funded by the European Commission, the IMI (Innovative Medicines Initiatives) and the NIH and has been recognized by several awards nationally and internationally. As part of her commitment to international development, Dr. Lopez-Correa funded the not for profit organization ODNS (Organisation pour le Développement avec des Nouvelles Solidarités) in 2012 and has been involved in several initiatives aiming at demonstrating the impact of genomics in developing countries.